Serum Institute clarifies COVID-19 vaccine pricing, `initial rates low due to advance funding`

Serum Institute clarifies COVID-19 vaccine pricing, `initial rates low due to advance funding`

Zee News

Published

Serum Institute of India (SII), which manufactures AstraZeneca's vaccine Covishield at its Pune facility, earlier this week announced a price of Rs 600 per dose and at Rs 400 for state governments and any new contract by the central government. This compared to Rs 150 per dose it charges the central government for the existing supplies.

Full Article